Dow Down 0.17% Nasdaq Down 0.28%

Ligand Pharmaceuticals Incorporated (LGND)

-NGM
46.99 Down 0.62(1.30%) Sep 30, 4:00PM EDT
|After Hours : 46.99 Up 0.00 (0.01%) Sep 30, 4:39PM EDT
Prev Close:47.61
Open:47.49
Bid:45.05 x 100
Ask:54.25 x 100
1y Target Est:84.80
Beta:1.23
Earnings Date:Oct 27 - Nov 6 (Est.)
Day's Range:46.32 - 48.04
52wk Range:43.57 - 80.42
Volume:568,236
Avg Vol (3m):437,175
Market Cap:976.45M
P/E (ttm):130.17
EPS (ttm):0.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for LGND

Comparison

Symbol% ChgMkt Cap
LGNDDown 1.30%976.45M
LLYDown 0.75%69.50B
MRKDown 0.22%171.00B
RHHBYUp 0.24%251.34B

Key Statistics

Forward P/E (1 yr):19.34
P/S (ttm):18.22
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.55
Quarterly EPS Est (Sep-14) :0.32
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback